Role of PET/MRI in Head and Neck Cancer

University of Pecs

Status: Completed

Conditions: Malignant Neoplasm; Benign Neoplasm; Head and Neck Cancer

Treatments: Radiation: Radiotherapy

Study type: Observational

Funder types: Other

Identifiers

NCT04360993

Pécs/ Oncoradiology

Details and patient eligibility

About

Study aim was to investigate the diagnostic role of Positron Emission Tomography / Magnetic Resonance Imaging (PET/MRI) in head and neck cancer.

Full description

This study was assessed the role of Diffusion weighted imaging (DWI) in discriminating between benign and malignant lesions in Head and neck cancer as well as studying the relationship between glucose metabolism (18F-FDG) and Apparent diffusion coefficient (ADC) for better tumor assessment.

Enrollment: 110 patients

Sex: All

Ages: 41 to 88 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Proved Head and neck cancer
• Underwent PET/CT and PET/MRI
• Lymph nodes due to primary Head and neck cancer.

For healthy subject:

• No previous history of malignancy.
• no inflammation or infection in the neck region.
• lymph node size <10mm.

Exclusion criteria

• patients treated before by radiotherapy / chemoradiotherapy
• patients underwent surgery
• artifacts

Trial design

110 participants in 1 patient group

Patients underwent PET/CT & PET/MRI

Description:

Patients with head and neck cancer were underwent PET/CT and PET/MRI for staging, assessment and follow up

Treatment:

Radiation: Radiotherapy